Martes, 26 Septiembre 2023
New evidence supports higher dose antimalarial to combat relapsing malaria
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries.